<DOC>
	<DOC>NCT01869985</DOC>
	<brief_summary>The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of HCP1104 and Eperisone Hydrochloride plus Aceclofenac.</brief_summary>
	<brief_title>Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers</brief_title>
	<detailed_description>The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of HCP1104 and Eperisone Hydrochloride plus Aceclofenac.</detailed_description>
	<mesh_term>Aceclofenac</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Eperisone</mesh_term>
	<criteria>Healthy male volunteers, age between 20 and 45 BMI of ＞20kg/m2 and ＜28kg/m2 subject Informed of the investigational nature of this study and voluntarily agree to participate in this study Use of any prescription medication within 14 days prior to Day 1 Use of any medication within 7 days prior to Day 1 Participation in another clinical study within 60 days prior to start of study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>HCP1104</keyword>
	<keyword>Eperisone Hydrochloride</keyword>
	<keyword>Aceclofenac</keyword>
</DOC>